tiprankstipranks
New Century Healthcare Holding Co. Ltd. (HK:1518)
:1518
Hong Kong Market
Want to see HK:1518 full AI Analyst Report?

New Century Healthcare Holding Co. Ltd. (1518) AI Stock Analysis

1 Followers

Top Page

HK:1518

New Century Healthcare Holding Co. Ltd.

(1518)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
HK$0.53
▼(-34.13% Downside)
Action:Reiterated
Date:05/14/26
The score is held down primarily by the 2025 financial reversal (losses, margin pressure, and sharply weaker cash generation) and bearish technical setup (below key moving averages with negative MACD). Valuation is mixed: the dividend yield is supportive, but the negative P/E underscores current unprofitability.
Positive Factors
Stable healthcare services model
A hospital network delivering inpatient and outpatient clinical care underpins recurring demand and service stickiness. This business model benefits from structural healthcare needs, predictable utilization patterns, and entrenched local relationships, supporting resilient revenue over months.
Negative Factors
Revenue and profit deterioration
A ~20% revenue decline with a simultaneous swing to sizable net loss and negative operating profit indicates weakened demand or margin pressure. Such deterioration erodes internal funding, limits reinvestment capacity, and raises the risk that profitability does not recover within a several-month horizon without structural fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable healthcare services model
A hospital network delivering inpatient and outpatient clinical care underpins recurring demand and service stickiness. This business model benefits from structural healthcare needs, predictable utilization patterns, and entrenched local relationships, supporting resilient revenue over months.
Read all positive factors

New Century Healthcare Holding Co. Ltd. (1518) vs. iShares MSCI Hong Kong ETF (EWH)

New Century Healthcare Holding Co. Ltd. Business Overview & Revenue Model

Company Description
New Century Healthcare Holding Co. Ltd. (1518) is a leading healthcare service provider based in China, primarily focused on delivering high-quality medical services and products. The company operates in various sectors, including hospital managem...
How the Company Makes Money
null...

New Century Healthcare Holding Co. Ltd. Financial Statement Overview

Summary
Financials are mixed with elevated volatility: 2025 revenue fell ~20% YoY and the company swung to a sizable net loss with negative operating profit and weaker gross margin. The balance sheet is relatively stable with moderate leverage and positive equity, but cash flow weakened sharply in 2025 versus strong 2023–2024 (though FCF stayed positive).
Income Statement
38
Negative
Balance Sheet
56
Neutral
Cash Flow
44
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue600.10M846.50M933.07M636.46M632.57M
Gross Profit175.88M344.96M407.09M202.14M198.74M
EBITDA3.28M170.68M234.18M-209.54M41.78M
Net Income-115.31M47.38M84.16M-297.73M-101.46M
Balance Sheet
Total Assets745.64M939.13M944.39M901.38M1.27B
Cash, Cash Equivalents and Short-Term Investments283.58M354.52M304.31M226.08M223.84M
Total Debt166.31M185.83M206.07M217.02M280.24M
Total Liabilities391.51M430.26M492.63M540.03M586.66M
Stockholders Equity428.97M553.83M522.28M438.26M737.46M
Cash Flow
Free Cash Flow8.29M114.10M148.21M66.16M9.10M
Operating Cash Flow17.93M135.92M158.92M76.28M22.25M
Investing Cash Flow-62.61M-21.03M-8.64M-23.07M-15.74M
Financing Cash Flow-79.16M-65.18M-73.07M-57.26M-79.84M

New Century Healthcare Holding Co. Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.80
Price Trends
50DMA
0.56
Positive
100DMA
0.60
Negative
200DMA
0.69
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
50.97
Neutral
STOCH
39.58
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1518, the sentiment is Neutral. The current price of 0.8 is above the 20-day moving average (MA) of 0.56, above the 50-day MA of 0.56, and above the 200-day MA of 0.69, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.97 is Neutral, neither overbought nor oversold. The STOCH value of 39.58 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1518.

New Century Healthcare Holding Co. Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
HK$376.45M4.984.28%7.10%-2.78%-24.77%
71
Outperform
HK$662.10M2.286.66%9.14%-1.48%549.60%
56
Neutral
HK$476.77M15.0127.04%2.00%
54
Neutral
HK$1.50B256.570.48%0.49%-2.63%
52
Neutral
HK$303.64M4.113.54%3.75%9.74%32.37%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
HK$273.34M-2.48-25.22%3.16%-29.10%-343.29%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1518
New Century Healthcare Holding Co. Ltd.
0.56
-0.63
-52.94%
HK:1419
Human Health Holdings Ltd.
0.78
-0.01
-1.27%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.94
0.20
11.49%
HK:3869
Hospital Corporation of China Ltd
3.43
-2.57
-42.83%
HK:3886
Town Health International Medical Group Ltd.
0.22
>-0.01
-3.93%
HK:0722
UMP Healthcare Holdings Limited
0.47
0.08
21.45%

New Century Healthcare Holding Co. Ltd. Corporate Events

New Century Healthcare Sets 2026 AGM to Renew Share Issuance Mandate and Board Seats
Apr 23, 2026
New Century Healthcare Holding Co. Ltd. has convened its annual general meeting for May 22, 2026, in Beijing, where shareholders will review and adopt the audited consolidated financial statements for the year ended December 31, 2025, along with t...
New Century Healthcare Strengthens Board with New Appointment and INED Upgrade
Apr 20, 2026
New Century Healthcare Holding has strengthened its board with the appointment of Zhao Qin as a non-executive director, effective April 20, 2026. Zhao, a 33-year-old finance professional with experience at Genertec Hong Kong International Capital ...
New Century Healthcare Reshapes Board and Key Committees
Apr 20, 2026
New Century Healthcare Holding Co. Ltd. has updated its board structure effective April 20, 2026, confirming Jason Zhou as chairman and chief executive officer, alongside senior executives Xin Hong as chief operating officer and Xu Han as chief fi...
New Century Healthcare Plans Governance Overhaul to Align with Updated HKEX Rules
Mar 27, 2026
New Century Healthcare Holding plans to replace its existing second amended and restated memorandum and articles of association with a third amended and restated version. The move reflects the need to align its constitutional documents with update...
New Century Healthcare Swings to Loss as Revenue and Patient Volumes Slide in 2025
Mar 27, 2026
New Century Healthcare reported a sharp deterioration in its 2025 financial performance, with revenue falling 29.1% year on year to about RMB600.1 million as both outpatient and inpatient business contracted. Outpatient revenue declined 24.8% and ...
New Century Healthcare Sets March 27 Board Meeting to Approve 2025 Results
Mar 13, 2026
New Century Healthcare Holding Co. Limited has scheduled a board meeting for March 27, 2026 to consider and approve the annual results for the year ended December 31, 2025. The meeting will also address other unspecified corporate matters, signali...
New Century Healthcare Issues Profit Warning as Demand Weakens
Mar 9, 2026
New Century Healthcare warned that it expects to post a loss attributable to owners of between RMB110 million and RMB125 million for 2025, reversing from a profit of about RMB47.4 million a year earlier. The company cited weaker demand for pediatr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 14, 2026